Chronic myeloid leukemia (CML) results from the clonal expansion of pluripotent hematopoietic stem cells containing the active BCR/ABL fusion gene produced by a reciprocal translocation of the ABL1 gene to the BCR gene. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.